Glaukos Corp GKOS 深 滬
已收盤 04-02 16:00:00 美东时间
112.77
+0.130
+0.12%
華盛通- 最 高113.895
- 今 開109.79
- 成交量 59.14万股
- 最 低 108.72
- 昨 收 112.64
- 總市值 65.50亿
- 52周最高 130.23
- 市盈率 靜 --
- 換手率 1.02%
- 52周最低 73.16
- 委 比 50.00%
- 總股本 5807.88万
- 歷史最高 163.71
- 量 比 0.79
- 振 幅 4.59%
- 歷史最低 14.25
- 每 手 1
- 風險率 12.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Glaukos SVP and Chief Financial Officer Alex R. Thurman disposes of common shares; $505,399 total value
Glaukos SVP and Chief Financial Officer Alex R. Thurman disposes of common shares; $505,399 total value Glaukos SVP and Chief Financial Officer Alex Thurman reported disposing of 1,230 shares of common stock on 03/23/2026 at USD 106.84 per share. He also reported disposing of 1,521 shares on 03/24/2
03-26 08:41
Glaukos Highlights Interventional Ophthalmology Strategy in Investor Update
Glaukos ( ($GKOS) ) has issued an update. Glaukos Corporation released an inves...
03-02 20:54
财报速睇 | Glaukos Corp 2025财年年度营收5.07亿美元，同比增长32.4%；归母净利润亏损0.02亿美元，由盈转亏
华盛资讯3月2日讯，Glaukos Corp公布2025财年年度业绩，公司年度营收5.07亿美元，同比增长32.4%，归母净利润亏损0.02亿美元，由盈转亏。
03-02 20:25
Glaukos Publishes Investor Presentation on Interventional Glaucoma and Keratoconus Therapies
Glaukos Publishes Investor Presentation on Interventional Glaucoma and Keratoconus Therapies Glaukos Corporation released an investor presentation outlining its focus on interventional glaucoma and interventional keratoconus. The company highlighted its commercial portfolio and pipeline, including i
03-02 20:23
Glaukos Director Aimee S Weisner Disposes of Common Shares
Glaukos Director Aimee S Weisner Disposes of Common Shares Aimee S. Weisner, Director of Glaukos Corporation, reported a disposal of the company’s common shares. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using genera
02-24 06:25
美股大行评级 | 潜在涨幅216.49%！杰富瑞上调BioAge Labs目标价至62美元，评级升至"买入"
今日重点评级关注：杰富瑞：上调BioAge Labs评级至"买入"，目标价从9美元升至62美元；RBC Capital：维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级，目标价从21美元升至22美元
02-19 16:21
Wingstop Posts Upbeat Q4 Earnings, Joins Caesars Entertainment, Garmin, Sabre And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 250 points on ...
02-18 23:18
These Analysts Boost Their Forecasts On Glaukos Following Q4 Results
Glaukos Corp (NYSE:GKOS) reported mixed results for the fourth quarter on Tuesd...
02-18 22:34
BTIG Reiterates Buy on Glaukos, Maintains $131 Price Target
BTIG analyst Ryan Zimmerman reiterates Glaukos (NYSE:GKOS) with a Buy and maintains $131 price target.
02-18 18:18
电话会总结 ｜ Glaukos(GKOS)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Glaukos业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **季度业绩（2025年第四季度）：** - 合并净销售额：1.431亿美元，同比增长36%（报告基础）和34%（恒定汇率基础） - 美国青光眼业务：8,640万美元，同比增长53% - 国际青光眼业务：3,280万美元，同比增长18%（报告基础）和13%（恒定汇率基础） - 角膜健康业务：2,400万美元，同比增长12% **年度业绩（2025财年）：** - 合并净销售额：5.074亿美元，同比增长32% - iDose TR全年销售额：约1.36亿美元 - Photr
02-18 12:16
